# ATEBRIOZ
> **NDA221198** · New Drug Application · Sponsor: INCYTE CORP · Approved 2026-09-25
## Drug
- **FDA Application Number:** NDA221198
- **Application type:** New Drug Application
- **Brand name:** ATEBRIOZ
- **Generic name:** Zilurgisertib
- **Active ingredients:** ZILURGISERTIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INCYTE CORP
- **First approval:** 2026-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221198)
---
*MORVS · CC0 1.0*